Stericycle Inc (SRCL) Shares Bought by LGT Capital Partners LTD.
LGT Capital Partners LTD. increased its position in shares of Stericycle Inc (NASDAQ:SRCL) by 24.0% during the first quarter, Holdings Channel reports. The institutional investor owned 62,000 shares of the business services provider’s stock after buying an additional 12,000 shares during the period. LGT Capital Partners LTD. owned approximately 0.07% of Stericycle worth $5,139,000 as of its most recent SEC filing.
Other large investors also recently added to or reduced their stakes in the company. AMG Funds LLC boosted its stake in Stericycle by 16.0% in the fourth quarter. AMG Funds LLC now owns 26,331 shares of the business services provider’s stock worth $2,029,000 after buying an additional 3,624 shares in the last quarter. Advent International Corp MA boosted its stake in shares of Stericycle by 105.2% in the fourth quarter. Advent International Corp MA now owns 43,100 shares of the business services provider’s stock valued at $3,320,000 after buying an additional 22,100 shares during the period. CGOV Asset Management acquired a new stake in shares of Stericycle during the third quarter valued at about $8,365,000. BlackRock Institutional Trust Company N.A. boosted its stake in shares of Stericycle by 1.1% in the third quarter. BlackRock Institutional Trust Company N.A. now owns 2,193,594 shares of the business services provider’s stock valued at $175,795,000 after buying an additional 24,136 shares during the period. Finally, Schaper Benz & Wise Investment Counsel Inc. WI boosted its stake in shares of Stericycle by 27.2% in the third quarter. Schaper Benz & Wise Investment Counsel Inc. WI now owns 124,723 shares of the business services provider’s stock valued at $9,995,000 after buying an additional 26,665 shares during the period. 94.49% of the stock is currently owned by hedge funds and other institutional investors.
Shares of Stericycle Inc (NASDAQ:SRCL) traded up 0.54% during mid-day trading on Friday, reaching $85.58. 443,488 shares of the company traded hands. The company’s 50 day moving average is $82.17 and its 200 day moving average is $78.34. The stock has a market capitalization of $7.30 billion, a price-to-earnings ratio of 41.14 and a beta of 0.08. Stericycle Inc has a 52-week low of $71.52 and a 52-week high of $125.04.
Stericycle (NASDAQ:SRCL) last announced its earnings results on Wednesday, February 15th. The business services provider reported $1.00 EPS for the quarter, beating the consensus estimate of $0.93 by $0.07. The business had revenue of $906.40 million for the quarter, compared to the consensus estimate of $902.62 million. Stericycle had a return on equity of 15.33% and a net margin of 7.52%. During the same period last year, the business posted $1.11 EPS. On average, equities analysts forecast that Stericycle Inc will post $4.62 earnings per share for the current year.
ILLEGAL ACTIVITY NOTICE: This report was first published by Financial Market News and is owned by of Financial Market News. If you are viewing this report on another website, it was illegally stolen and republished in violation of U.S. and international copyright and trademark laws. The legal version of this report can be accessed at http://www.financial-market-news.com/stericycle-inc-srcl-shares-bought-by-lgt-capital-partners-ltd/1406001/.
Several equities research analysts have issued reports on the stock. Royal Bank of Canada set a $74.00 target price on shares of Stericycle and gave the stock a “sell” rating in a research note on Saturday, January 21st. Barclays PLC initiated coverage on shares of Stericycle in a research report on Thursday, April 13th. They set an “overweight” rating and a $100.00 price target on the stock. Goldman Sachs Group Inc raised shares of Stericycle from a “sell” rating to a “neutral” rating and boosted their price target for the company from $62.00 to $79.00 in a research report on Tuesday, March 7th. Stifel Nicolaus set a $90.00 price target on shares of Stericycle and gave the company a “buy” rating in a research report on Monday, February 6th. Finally, Zacks Investment Research raised shares of Stericycle from a “sell” rating to a “hold” rating in a research report on Saturday, February 18th. Two analysts have rated the stock with a sell rating, nine have given a hold rating and five have given a buy rating to the company. The stock has an average rating of “Hold” and a consensus price target of $91.82.
In related news, Director Mike S. Zafirovski bought 2,920 shares of the company’s stock in a transaction that occurred on Thursday, February 23rd. The shares were acquired at an average cost of $85.67 per share, for a total transaction of $250,156.40. Following the acquisition, the director now owns 2,920 shares in the company, valued at approximately $250,156.40. The purchase was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Robert S. Murley bought 1,000 shares of the company’s stock in a transaction that occurred on Wednesday, February 1st. The shares were bought at an average price of $76.22 per share, for a total transaction of $76,220.00. The disclosure for this purchase can be found here. Company insiders own 3.30% of the company’s stock.
Stericycle Company Profile
Stericycle, Inc is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other.
Want to see what other hedge funds are holding SRCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stericycle Inc (NASDAQ:SRCL).
Receive News & Ratings for Stericycle Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc and related companies with MarketBeat.com's FREE daily email newsletter.